Content about Health & Wellness

June 24, 2011

A recent study published in Panminerva Medica found that a pycnogenol and coenzyme-Q10 combination (PycnoQ10) taken by stable heart failure patients as an adjunct to medical treatment naturally strengthens the heart, increasing the blood volume ejected with each beat.

HOBOKEN, N.J. — A recent study published in Panminerva Medica found that a pycnogenol and coenzyme-Q10 combination (PycnoQ10) taken by stable heart failure patients as an adjunct to medical treatment naturally strengthens the heart, increasing the blood volume ejected with each beat.

As a result, the oxygen-rich blood supply to the organs improves, and patients become more physically energetic.

Pycnogenol is an antioxidant plant extract from the bark of the French maritime pine tree and has been clinically proven to improve endothelial function and blood flow.

June 24, 2011

The charitable arm of Bristol-Myers Squibb has awarded five grants totaling $1.5 million to organizations that encourage African-American women with Type 2 diabetes to better manage their disease.

NEW YORK — The charitable arm of Bristol-Myers Squibb has awarded five grants totaling $1.5 million to organizations that encourage African-American women with Type 2 diabetes to better manage their disease.

June 24, 2011

Bolthouse Farms has announced that the American Heart Association has certified its 100% carrot juice, baby carrots and cello carrots.

BAKERSFIELD, Calif. — Bolthouse Farms has announced that the American Heart Association has certified its 100% carrot juice, baby carrots and cello carrots.

The products now will tout a heart checkmark on each label, the company said, which indicates the products meet the nutritional standards the American Heart Association sets for foods and beverages.

June 24, 2011

Patients with inflammatory conditions may have lower rates of diabetes if they take drugs commonly used to treat arthritis, according to a new study published in the Journal of the American Medical Association.

NEW YORK — Patients with inflammatory conditions may have lower rates of diabetes if they take drugs commonly used to treat arthritis, according to a new study published in the Journal of the American Medical Association.

The study, conducted by researchers at Brigham and Women’s Hospital in Boston, examined nearly 14,000 patients with rheumatoid arthritis and psoriasis who took disease-modifying anthrheumatic drugs. Patients who have these diseases have significantly increased risk of developing cardiovascular disease and diabetes.

June 24, 2011

Despite the expansion of the diabetes drug market over the past 20 years, the rate of diabetic kidney disease has become more prevalent in the United States.

NEW YORK — Despite the expansion of the diabetes drug market over the past 20 years, the rate of diabetic kidney disease has become more prevalent in the United States.

June 24, 2011

The Food and Drug Administration has accepted a resubmission by Endo Pharmaceuticals of a regulatory application for an opioid pain drug designed to thwart abuse, Endo said.

CHADDS FORD, Pa. — The Food and Drug Administration has accepted a resubmission by Endo Pharmaceuticals of a regulatory application for an opioid pain drug designed to thwart abuse, Endo said.

The agency had declined to approve Endo’s Opana ER (oxymorphone hydrochloride) in January for reasons that the company did not specify, though the agency did not request additional clinical studies in its statement, known as a complete response letter.

June 24, 2011

A Food and Drug Administration expert panel has recommended approval of a drug made by Shire for a rare immune system disorder, the drug maker said.

DUBLIN — A Food and Drug Administration expert panel has recommended approval of a drug made by Shire for a rare immune system disorder, the drug maker said.

Shire said the FDA’s Pulmonary-Allergy Drugs Advisory Committee recommended approval of Firazyr (icatibant) for treating acute hereditary angioedema attacks in adults. The committee also voted 11-1 to recommend approval of self-administration of the drug by patients.

HAE is a genetic and potentially fatal immune system disorder that causes swelling of the face and airways and result in airway blockage.

June 24, 2011

It seems that intensive-dose statin therapy is linked with a higher risk of onset diabetes, compared with moderate-dose therapy, according to an analysis published in the Journal of the American Medical Association.

NEW YORK — It seems that intensive-dose statin therapy is linked with a higher risk of onset diabetes, compared with moderate-dose therapy, according to an analysis published in the Journal of the American Medical Association.

The analysis, which pooled data from previously published clinical trials, found that among 32,752 nondiabetic participants:

  • 2,749 participants (8.4%) developed diabetes. Among them, 1,449 were assigned intensive-dose therapy, while 1,300 assigned moderate-dose therapy;

June 24, 2011

Lelo on Thursday launched Intimina by Lelo, a new brand of intimate wellness products positioned as a premium to what’s on the shelf today.

SAN JOSE, Calif. — Lelo on Thursday launched Intimina by Lelo, a new brand of intimate wellness products positioned as a premium to what’s on the shelf today.

The new line of products — a line of personal massagers, pelvic floor exercisers, hygienic cleansers and feminine moisturizers — will be available to ship this summer.

June 24, 2011

A generic drug made by Mylan for Crohn’s disease does not infringe on the patent for the branded drug, a federal court ruled Thursday.

PITTSBURGH — A generic drug made by Mylan for Crohn’s disease does not infringe on the patent for the branded drug, a federal court ruled Thursday.

Mylan said the U.S. District Court for the District of Delaware ruled that Mylan’s regulatory approval application for budesonide capsules in the 3-mg strength does not violate the patent for the branded drug, AstraZeneca’s Entocort EC.

June 24, 2011

The Food and Drug Administration has declined to approve an investigative painkiller made by Pfizer, the drug maker said Friday.

NEW YORK — The Food and Drug Administration has declined to approve an investigative painkiller made by Pfizer, the drug maker said Friday.

The FDA issued a complete response letter for Remoxy (oxycodone) extended-release capsules, which Pfizer is developing under a partnership with Pain Therapeutics. Pain Therapeutics originally developed the drug using Durect’s Oradur technology, which is designed to prevent tampering by drug abusers, in collaboration with King Pharmaceuticals. Pfizer took control of development of the drug when it acquired King in February.

June 24, 2011

Purdue Products on Thursday announced new packaging and product design across its Senokot Laxatives Comfort Promise line.

NEW YORK — Purdue Products on Thursday announced new packaging and product design across its Senokot Laxatives Comfort Promise line.

The packaging makeover includes Senokot-S Tablets, a laxative plus stool softener for those who experience occasional constipation which may be caused by certain medications, and Senokot To Go, a convenient, easy-to-carry four-pack choice for busy consumers with on-the-go schedules.

June 23, 2011

Walmart is working with Colgate’s Bright Smiles, Bright Futures program to create a new initiative that offers free dental screenings and oral health education to children in need living in the Dallas area.

NEW YORK — Walmart is working with Colgate’s Bright Smiles, Bright Futures program to create a new initiative that offers free dental screenings and oral health education to children in need living in the Dallas area.

June 23, 2011

Novo Nordisk has teamed up with actor Chris Noth to underscore the importance of early diabetes screening and detection.

PRINCETON, N.J. — Novo Nordisk has teamed up with actor Chris Noth to underscore the importance of early diabetes screening and detection.

Noth will serve as an ambassador for the national education program Ask.Screen.Know., Novo Nordisk said. As an ambassador, Noth will encourage Americans ages 45 years or older to get tested for diabetes and talk to a healthcare professional about the risk factors through a public service announcement and online at AskScreenKnow.com.

June 23, 2011

Americans still believe that breakfast is the most important meal of the day, although many find it difficult to eat breakfast due to hectic schedules, according to a survey sponsored by Kellogg's.

BATTLE CREEK, Mich. — Americans still believe that breakfast is the most important meal of the day, although many find it difficult to eat breakfast due to hectic schedules, according to a survey sponsored by Kellogg's.

The survey, which consisted of more than 14,000 respondents across varying ethnicities, income levels, geographic regions and ages, found that while more than half (54%) of all adult respondents would like to eat breakfast every day, in reality only one-third (34%) actually do.

June 23, 2011

Bipartisan legislation that is aimed to eliminate waste, fraud and abuse in Medicare and Medicaid programs has been introduced to Congress.

ALEXANDRIA, Va. — Bipartisan legislation that is aimed to eliminate waste, fraud and abuse in Medicare and Medicaid programs has been introduced to Congress.

Sens. Tom Carper, D-Del., and Tom Coburn, R-Okla., said that the Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers’ Dollars Act, which was unveiled Wednesday, would address the aforementioned problems, which often lead to tens of billions of dollars lost to waste and fraud in Medicare and Medicaid every year, the senators said.

June 23, 2011

One-third of spending on mental health in the United States, or $42 million, goes toward anxiety disorders, according to a new report by Companies & Markets.

LONDON — One-third of spending on mental health in the United States, or $42 million, goes toward anxiety disorders, according to a new report by Companies & Markets.

The report found that the global anxiety disorders market would likely rise in value to $5.9 billion by 2017, thanks to increasing stress levels exacerbated by an unstable economic climate, the aging of the population, an increase in patients with anxiety disorders and new drug development.

June 23, 2011

The Supreme Court has struck down a law in Vermont designed to encourage generic drug usage by limiting the sharing of information about what branded drugs doctors prescribe, so that drug companies could use it when crafting sales pitches, according to published reports.

WASHINGTON — The Supreme Court has struck down a law in Vermont designed to encourage generic drug usage by limiting the sharing of information about what branded drugs doctors prescribe, so that drug companies could use it when crafting sales pitches, according to published reports.

June 23, 2011

Locating retail health clinics and urgent care centers just got easier for patients seeking nonemergency care when their regular doctors are not available, thanks to an emergency room program and education campaign that incorporates Google Maps launched by WellPoint's affiliated health plans.

INDIANAPOLIS — Locating retail health clinics and urgent care centers just got easier for patients seeking nonemergency care when their regular doctors are not available, thanks to an emergency room program and education campaign that incorporates Google Maps launched by WellPoint's affiliated health plans.

June 23, 2011

Wockhardt has launched three new drugs in the United States over the last three weeks, the Indian generic drug maker said.

MUMBAI, India — Wockhardt has launched three new drugs in the United States over the last three weeks, the Indian generic drug maker said.

Wockhardt announced the Food and Drug Administration's approval and the launch of the company's antibacterial drug levofloxacin, a generic version of Johnson & Johnson’s Levaquin, in the 250-mg, 500-mg and 750-mg strengths.

June 22, 2011

Axium Healthcare Pharmacy was named the recipient of a 2011 SMART Award in the healthcare and life sciences category by the Association for Corporate Growth's Orlando chapter, the specialty pharmacy provider announced last week.

LAKE MARY, Fla. — Axium Healthcare Pharmacy was named the recipient of a 2011 SMART Award in the healthcare and life sciences category by the Association for Corporate Growth's Orlando chapter, the specialty pharmacy provider announced last week.

Each year, ACG Orlando presents SMART Awards as part of its continuing commitment to facilitate relationships among middle-market companies, capital sources and professionals active in corporate finance throughout Central Florida, Axium said. ACG Orlando hosted its fifth annual SMART Awards luncheon in late May.

June 22, 2011

Endo Pharmaceuticals has acquired a provider of devices and therapies for male and female pelvic health.

CHADDS FORD, Pa. — Endo Pharmaceuticals has acquired a provider of devices and therapies for male and female pelvic health.

Endo said its acquisition of American Medical Systems has boosted the drug maker's devices and services business segment, and the combination of AMS with Endo's existing platform will provide additional cost-effective solutions across the entire urology spectrum.

The company announced its definitive agreement to acquire AMS in a cash transaction valued for approximately $2.9 billion.

June 22, 2011

The Department of Health and Human Services’ National Diabetes Education Program has unveiled a series of videos designed to help people make lifestyle changes and cope with the demands of diabetes.

WASHINGTON — The Department of Health and Human Services’ National Diabetes Education Program has unveiled a series of videos designed to help people make lifestyle changes and cope with the demands of diabetes.

June 22, 2011

Rep. Tom Marino, R-Pa., on Monday propositioned a bill that would allow independent drug stores to band together in an effort to increase their collective pharmaceutical buying power.

KINGSTON, Pa. — Rep. Tom Marino, R-Pa., on Monday propositioned a bill that would allow independent drug stores to band together in an effort to increase their collective pharmaceutical buying power.

June 22, 2011

The Food and Drug Administration has approved a medication designed to treat acute and chronic moderate to severe pain, where the use of an opioid analgesic is suitable.

NEW YORK — The Food and Drug Administration has approved a medication designed to treat acute and chronic moderate to severe pain, where the use of an opioid analgesic is suitable.

Pfizer and Acura Pharmaceuticals said that their drug Oxecta (oxycodone HCl, USP tablets) is the first tamper-resistant medication designed to deter abuse and misuse with Aversion technology, which is being licensed by Pfizer from Acura.